Summary: New research reveals how repeated cannabis use during adolescence is linked to measurable changes in deep brain regions that govern motivation and reward. Using advanced MRI measures of tissue iron, a key biological cofactor for dopamine production, the study shows that frequent cannabis use — especially of high‑potency products — is associated with reduced markers of dopamine‑related development in teenagers.
Researchers applied specialized MRI techniques to noninvasively quantify subcortical tissue iron, an established proxy for dopamine system maturation. Their findings indicate that adolescents who use cannabis regularly show lower tissue iron in dopamine‑dense regions, suggesting interference with the normal development of the brain’s reward circuitry.
Key Facts
- Critical window for dopamine maturation: Adolescence is a formative period when the dopamine system — which regulates motivation, reward learning, and goal‑directed behavior — undergoes essential development.
- Tissue iron as a biomarker: Brain tissue iron supports dopamine synthesis and normally increases through adolescence, making it a reliable, noninvasive MRI marker of healthy dopamine neurophysiology.
- Potency matters: The study found a dose‑response pattern: teens using higher‑potency cannabis products displayed larger reductions in tissue iron compared with teens using lower‑potency products or using infrequently.
- First MRI evidence in adolescents: This is the first study to directly examine the relationship between adolescent cannabis use and subcortical tissue iron levels in regions rich in dopamine signaling.
- Adult vs. adolescent effects: While acute THC can transiently raise dopamine in adults, chronic adult use has been linked to blunted dopamine release. This study addresses a gap by showing similar dopamine‑related alterations can occur during the brain’s developmental window.
- Public health implications: With roughly 10–20% of U.S. adolescents reporting past‑year cannabis use, early exposure may increase the risk of developing cannabis use disorder and heighten vulnerability to other substance use by altering reward circuitry during development.
- Next steps — longitudinal tracking: Lead author Dr. Sarah A. Thomas emphasizes the importance of following adolescents over time to determine whether early reductions in tissue iron predict later cognitive, motivational, or psychiatric outcomes.
Source: Brown University
A new study from Bradley Hospital researchers demonstrates that adolescent cannabis use is associated with alterations in brain regions involved in motivation and reward, with potential consequences for healthy development.
The investigators report that repeated cannabis use during adolescence correlates with reduced dopamine‑related neurophysiology, and this relationship is stronger among teens who use higher‑potency cannabis products. Their results were published in Neuropsychopharmacology.
“Adolescence is a critical window for brain development,” said lead author Sarah A. Thomas, PhD, a clinical psychologist and research scientist at the Bradley Hasbro Children’s Research Center and Assistant Professor of Psychiatry and Human Behavior (research) at the Warren Alpert Medical School of Brown University. “Our findings suggest that repeated cannabis use during this period may alter the dopamine system in ways that affect motivation, reward processing and vulnerability to addiction. Longitudinal follow‑up will be essential to see how these changes evolve.”
Approximately 10–20% of U.S. adolescents report past‑year cannabis use. Because the teenage brain is still maturing, it is more sensitive than the adult brain to cannabis exposure. Prior research has shown that adolescents who use cannabis are at higher risk of developing cannabis use disorder and of experimenting with other substances later in life. Disruption of the dopamine system is one plausible mechanism linking early cannabis use with these outcomes.
In adults, THC, the primary psychoactive component of cannabis, can transiently increase dopamine release. However, chronic use in adults has been associated with reduced dopamine function in some studies. Until now, few studies have directly assessed dopamine‑related development in adolescents. This research fills that gap by using MRI‑based tissue iron measures to index dopamine neurophysiology in a sample of teenagers.
Funded by the National Institute on Drug Abuse, the study enrolled 81 adolescents aged 14–17 who reported either minimal lifetime cannabis exposure or more frequent use. Participants completed detailed substance‑use assessments and underwent MRI scans that measured the inverse normalized T2* signal (1/nT2*), a metric sensitive to subcortical tissue iron. Lower 1/nT2* values indicate less tissue iron and, by extension, reduced dopamine‑related neurophysiology.
Analyses showed that lower tissue iron signals were associated with greater daily concentrate hits, longer hours spent high, higher overall use frequency, and increased cannabis use disorder severity. Post‑hoc analyses highlighted the ventral tegmental area (VTA) and other subcortical regions as key sites where these associations were strongest.
These findings align with animal and adult human studies linking cannabis to altered dopamine function, and they extend that evidence to a vulnerable developmental period. The study underscores the value of 1/nT2* as a noninvasive biomarker to detect neurobiological alterations related to adolescent cannabis use and suggests important avenues for future longitudinal research.
Key Questions Answered:
A: Tissue iron is essential for dopamine synthesis. During healthy adolescence, iron levels increase as the dopamine system matures, so measuring subcortical tissue iron with MRI provides a noninvasive way to assess whether cannabis use disrupts normal development.
A: The study observed a potency gradient: adolescents using stronger cannabis products had larger reductions in tissue iron, suggesting more pronounced interference with dopamine‑related neurophysiology.
A: The adolescent brain is actively developing its motivation and reward systems. Disruption during this formative period can alter the trajectory of dopamine system maturation, potentially reducing natural motivation and increasing susceptibility to future addiction.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal article was reviewed in full by the editorial team.
- Additional context was provided by staff writers to clarify implications for adolescent health and public policy.
About this neuroscience and CUD research news
Author: Kelly Brennan
Source: Brown University
Contact: Kelly Brennan – Brown University
Image: The image is credited to Neuroscience News
Original Research: Closed access. “The role of subcortical brain tissue iron as an indicator of dopamine neurophysiology in adolescent cannabis use” by Sarah A. Thomas et al., published in Neuropsychopharmacology. DOI: 10.1038/s41386-026-02444-9
Abstract
The role of subcortical brain tissue iron as an indicator of dopamine neurophysiology in adolescent cannabis use
Approximately 10–20% of U.S. adolescents report past‑year cannabis use. Although regular cannabis use beginning in adolescence is expected to blunt dopamine‑related neurophysiology, methodological limitations have previously prevented direct testing in teenagers. Subcortical tissue iron measured with MRI provides a noninvasive index of neurophysiology that supports dopamine function. This study examined cannabis use quantity, frequency, and problems in relation to tissue iron in regions with high dopamine activity, hypothesizing that greater cannabis exposure would be linked to lower tissue iron.
Eighty‑one adolescents (ages 14–17; 64.2% female) with limited alcohol and nicotine use and no other illicit substance use completed substance‑use assessments and MRI scans. The inverse normalized T2* measure (1/nT2*), derived from resting‑state functional scans and interpreted such that lower values indicate less tissue iron, was calculated within targeted subcortical regions. Lower 1/nT2* signal was associated with more daily concentrate hits, greater hours spent high, higher use frequency, and increased cannabis use disorder severity, with post‑hoc analyses implicating the ventral tegmental area. These results are consistent with reduced dopamine‑related neurophysiology associated with cannabis use in adult and animal studies and have implications for understanding adolescent cannabis use disorder development.